Actionable news
All posts from Actionable news
Actionable news in CARA: CARA THERAPEUTICS Inc,

Cara Therapeutics Rises on FDA Judgment

Cara Therapeutics Inc. (NASDAQ: CARA) saw its shares jump early on Wednesday after the U.S. Food and Drug Administration (FDA) made a favorable judgment for them. The company announced that it has received notice from the FDA concerning removal of the clinical hold on its adaptive Phase 3 trial of I.V. CR845 for postoperative pain.

Previously, this clinical hold was the result of a protocol-specified stopping criterion, based on elevated serum sodium levels, which was met during the first phase of the study.

After the fact, a review of the unblinded safety data from the first 90 patients was completed by...